These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6606041)

  • 1. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
    J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
    Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
    Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of the in vivo antinuclear antibody phenomenon.
    Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE
    Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal nuclear immunoglobulin deposition in connective tissue diseases.
    Rodrigues CJ; de Oliveira RM; Taniwaki NN; Bueno C; Marchiori P; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(4):154-7. PubMed ID: 2135825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nucleolar, homogeneous and peripheral fluorescence of epidermal nuclei in direct immunofluorescence: 4 cases (author's transl)].
    Morel P; Allègre P; Civatte J
    Ann Dermatol Venereol; 1979 Apr; 106(4):361-4. PubMed ID: 384881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease.
    Reimer G; Huschka U; Keller J; Kammerer R; Hornstein OP
    Br J Dermatol; 1983 Jul; 109(1):27-36. PubMed ID: 6344904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal nucleolar IgG deposition in clinically normal skin: clinical and serologic features of eight patients.
    Prystowsky SD; Gilliam JN; Tuffanelli DL
    Arch Dermatol; 1978 Apr; 114(4):536-8. PubMed ID: 348111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear deposits of immunoglobulins in skin of patients with systemic lupus erythematosus.
    Shu S; Provost T; Croxdale MB; Reichlin M; Beutner EH
    Clin Exp Immunol; 1977 Feb; 27(2):238-44. PubMed ID: 300310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory characteristics of patients with speckled pattern antinuclear antibodies.
    McMillan SA; Fay AC; Taggart AJ; McCrea JD; Roberts SD; Boyd MW; Nelson JK; Haire M
    Ulster Med J; 1986 Oct; 55(2):112-7. PubMed ID: 3492803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of antinuclear antibodies.
    Meryhew NL; Messner RP; Tan EM
    J Rheumatol; 1983 Dec; 10(6):913-9. PubMed ID: 6363697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of antinuclear antibodies in progressive systemic sclerosis].
    Scagliusi P; De Lucia M; Di Luca ML; Pannarale M; Pipitone V
    Minerva Med; 1984 Feb; 75(5):161-6. PubMed ID: 6366619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct immunofluorescent findings in scleroderma syndromes.
    Connolly SM; Winkelmann RK
    Acta Derm Venereol; 1981; 61(1):29-36. PubMed ID: 6164211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma.
    Kleinsmith DM; Heinzerling RH; Burnham TK
    Arch Dermatol; 1982 Nov; 118(11):882-5. PubMed ID: 6753766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
    Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
    Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of speckled staining of epidermal nuclei in direct immunofluorescence. 10 cases (author's transl)].
    Morel P; Peltier AP; Allegre P; Civatte J
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2377-80. PubMed ID: 353722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antinuclear antibodies, patterns and characteristics obtained by immunofluorescence. The importance of the IgA, IgM and IgG isotypes].
    Arcavi M; Dadone J
    Medicina (B Aires); 2009; 69(5):502-6. PubMed ID: 19897433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of human skin to demonstrate antinuclear antibodies in lepromatous leprosy patients.
    Lamas-Robles C; González-Mendoza A; Pérez-Suárez G; Mejía-Arreguín S
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):373-7. PubMed ID: 3876399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial aspects of mixed connective tissue disease (MCTD). I. Occurrence of systemic lupus erythematosus in another member in two families and aggregation of MCTD in another family.
    Ramos-Niembro F; Alarcon-Segovia D
    J Rheumatol; 1978; 5(4):433-40. PubMed ID: 310886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.